Siga Technologies (SIGA) Non-Current Debt (2012 - 2019)
Siga Technologies' (SIGA) quarterly Non-Current Debt came in at $78.9 million in Q3 2019, up 6.04% YoY from $74.4 million in Q3 2018, and up 1.46% on a QoQ basis from $77.8 million in Q2 2019.
Siga Technologies (SIGA) Non-Current Debt (2012 - 2019) Analysis & Trends
Siga Technologies (SIGA) has 7 years of Non-Current Debt data on file, last reported at $78.9 million in Q3 2019.
- Quarterly Non-Current Debt rose 6.04% year-over-year to $78.9 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $78.9 million (up 6.04% YoY) and the FY2018 annual result came in at $75.5 million, up 6.33% from the prior year.
- Non-Current Debt grew to $78.9 million in Q3 2019, from $77.8 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $78.9 million in Q3 2019 to a low of $66.6 million in Q4 2016.
- A 4-year average of $72.7 million and a median of $72.7 million in 2018 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2017 — Non-Current Debt grew 6.76% — and 2019, when it advanced 6.04%.
- Tracing SIGA's Non-Current Debt over 4 years: stood at $66.6 million in 2016, then rose by 6.76% to $71.1 million in 2017, then increased by 6.33% to $75.5 million in 2018, then increased by 4.45% to $78.9 million in 2019.
- The last three Non-Current Debt figures came in at $78.9 million (Q3 2019), $77.8 million (Q2 2019), and $76.7 million (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 130.00 Mn |
| 10 | Siga Technologies | 214.10 Mn | 59.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 78.91 Mn |
| Jun 30, 2019 | 77.78 Mn |
| Mar 31, 2019 | 76.66 Mn |
| Dec 31, 2018 | 75.55 Mn |
| Sep 30, 2018 | 74.41 Mn |
| Jun 30, 2018 | 73.28 Mn |
| Mar 31, 2018 | 72.16 Mn |
| Dec 31, 2017 | 71.05 Mn |
| Sep 30, 2017 | 69.92 Mn |
| Jun 30, 2017 | 68.78 Mn |
| Mar 31, 2017 | 67.66 Mn |
| Dec 31, 2016 | 66.55 Mn |
| Dec 31, 2014 | 1.99 Mn |
| Sep 30, 2014 | 2.50 Mn |
| Jun 30, 2014 | 997,693.00 |
| Mar 31, 2014 | 1.49 Mn |
| Dec 31, 2013 | 1.99 Mn |
| Sep 30, 2013 | 2.48 Mn |
| Jun 30, 2013 | 2.98 Mn |
| Mar 31, 2013 | 3.47 Mn |